| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |